STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis
Authors:
Open Access
- 28 April 2005
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 19 (6) , 936-944
Abstract
Classical Hodgkin lymphoma (cHL) is a distinct malignancy of the immune system. Despite the progress made in the understanding of the biology of cHL, the transforming events remain to be elucidated. Recently, we demonstrated that the Janus kinase inhibitor AG490 blocked cellular proliferation and STAT3 phosphorylation in cHL. To explore the potential of constitutively activated STAT3 as a drug target and its role in cHL pathogenesis, different cHL cell lines were analyzed. Treatment of cHL cells by the protein tyrosine kinase inhibitor AG17 was associated with inhibition of cellular proliferation and cell cycle arrest. AG17 treatment was accompanied by decreased levels of STAT3 phosphorylation, whereas NF-κB and p38/SAPK2 signaling were not inhibited. Incubation with AG17 or AG490 sensitized cHL cells to CD95/Fas/Apo-1 or staurosporine-mediated apoptosis. Coincubation of tyrphostins with staurosporine was accompanied by rapid complete inhibition of STAT3 phosphorylation. RNA interference directed against STAT3 in L428 and L1236 cHL cells demonstrated that STAT3 is essential for cell proliferation of these cHL cells. In conclusion, these findings support the concept that STAT3 signaling is important in the pathogenesis of cHL and tyrphostins are agents for developing new therapeutic strategies.Keywords
This publication has 41 references indexed in Scilit:
- In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3Leukemia, 2004
- Defective Bax activation in Hodgkin B-cell lines confers resistance to staurosporine-induced apoptosisCell Death & Differentiation, 2002
- Transcriptional Activation by STAT6 Requires the Direct Interaction with NCoA-1Journal of Biological Chemistry, 2001
- Linkage between STAT Regulation and Epstein-Barr Virus Gene Expression in TumorsJournal of Virology, 2001
- CD40 Ligand - An Anti-Apoptotic Molecule in Hodgkin's DiseaseCancer Biotherapy and Radiopharmaceuticals, 2001
- Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptorsOncogene, 2000
- Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cellsLeukemia, 1999
- Defective IκBα in Hodgkin cell lines with constitutively active NF-κBOncogene, 1998
- Single cell analysis of Hodgkin/Reed–Sternberg cellsAnnals of Oncology, 1996
- Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitorNature, 1996